Gyre Therapeutics
GYRE
6.92
-0.12
-1.70%
Gyre Therapeutics
US · GYRE
#3470 by market cap
Listed 2006
6.92
-0.12
-1.70%
Live - 5344 symbols - heartbeat 342s ago
· 2026-10-08 09:51
Pre-market
7.04
0.00%
After-hours
7.04
0.00%
- Market cap
- 733.75M
- P/E (TTM)i
- -32.95
- P/Bi
- 6.80
- EPSi
- 0.02
- Div yieldi
- 0.00%
- 52W posi
- 37%
Reader sentiment
Are you bullish or bearish on GYRE?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Mixed / stable
- The number of reporting institutions increased by 1 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 68.57% -0.01pp
- Institutions
- 76 +1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Public Company60.61%
Individual/Insider5.74%
VC/PE Fund3.54%
Mutual Fund3.43%
Hedge Fund0.93%
Other25.69%
Top holders as of 2026-03-31
GNI Group Ltd.
60.36% · 64.01M sh
HongShan Capital Advisors Limited
3.54% · 3.75M sh
Songjiang Ma
2.65% · 2.81M sh
Ying Luo
2.42% · 2.57M sh
Vanguard Capital Management, LLC
0.97% · 1.03M sh
BlackRock
0.94% · 993.94K sh
Octagon Capital Advisors LP
0.90% · 954.42K sh
Weiguo Ye
0.66% · 700.00K sh
Geode Capital Management, LLC
0.50% · 532.95K sh
State Street Global Advisors
0.23% · 245.40K sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 23 buys · 24 sells
| Name | Role | Stake |
|---|---|---|
| GNI Group Ltd. | -- | 60.36% |
| Songjiang Ma | President & Board Member | 2.65% |
| Ying Luo | Chairperson | 2.42% |
| Weiguo Ye | Chief Operating Officer | 0.66% |
| Thomas Eastling | Director | 0.01% |
| Dan Weng | Director | -- |
| David M. Epstein | Director | -- |
| Ping Zhang | Lead Independent Director | -- |
| Renate Parry | Board Member | -- |
| Gordon Carmichael | Board Member | -- |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-06-17 | Weiguo Ye | Chief Operating Officer | Derivative Exercise and Sale | -11,000 | $0.75–6.35 |
| 2026-06-10 | Weiguo Ye | Chief Operating Officer | Derivative Exercise and Sale | -2,800 | $0.75–6.17 |
| 2026-06-09 | Dan Weng | Director | Other Derivative Acquisition | +40,000 | $5.95 |
| 2026-06-09 | David M. Epstein | Director | Other Derivative Acquisition | +40,000 | $5.95 |
| 2026-06-09 | Ping Zhang | Lead Independent Director | Other Derivative Acquisition | +40,000 | $5.95 |
| 2026-06-09 | Renate Parry | Board Member | Other Derivative Acquisition | +40,000 | $5.95 |
| 2026-06-09 | Gordon Carmichael | Board Member | Other Derivative Acquisition | +40,000 | $5.95 |
| 2026-06-09 | Weiguo Ye | Chief Operating Officer | Derivative Exercise and Sale | -20,918 | $0.75–6.21 |
| 2026-06-09 | Rodney Nussbaum | Director | Other Derivative Acquisition | +40,000 | $5.95 |
| 2026-06-07 | Ying Luo | Chairperson | Other Derivative Acquisition | +120,000 | $6.05 |
| 2026-06-07 | Joshua Bergmann | General Counsel | Other Derivative Acquisition | +50,000 | $6.05 |
| 2026-06-04 | Weiguo Ye | Chief Operating Officer | Derivative Exercise and Sale | -34,976 | $0.75–6.40 |
| 2026-05-25 | Weiguo Ye | Chief Operating Officer | Derivative Exercise and Sale | -7,500 | $0.75–6.10 |
| 2026-05-20 | Weiguo Ye | Chief Operating Officer | Derivative Exercise and Sale | -22,220 | $0.75–6.15 |
| 2026-05-18 | Weiguo Ye | Chief Operating Officer | Derivative Exercise and Sale | -9,320 | $0.75–6.62 |
| 2026-05-14 | Weiguo Ye | Chief Operating Officer | Derivative Exercise and Sale | -28,680 | $0.75–6.91 |
| 2026-05-13 | Ping Zhang | Lead Independent Director | Derivative Sale to Issuer | -250,000 | -- |
| 2026-05-12 | Weiguo Ye | Chief Operating Officer | Intent to Sell (Form 144) | -300,000 | $7.07 |
| 2026-05-05 | Ying Luo | Chairperson | Automatic Disposition | -10,315 | $8.01–8.04 |
| 2026-05-03 | Thomas Eastling | Director | Other Derivative Acquisition | +408,757 | $0.32–5.98 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 09:51:25 · For reference only, not investment advice and not tailored to your situation.